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Iranian soldiers were attacked with chemical bombs, rockets and artillery shells 387 times during the 8-years war by
Iraq (1980–1988). More than 1,000 tons of sulfur mustard gas was used in the battlefields by the Iraqis against
Iranian people. A high rate of morbidities occurred as the result of these attacks. This study aimed to evaluate the
delayed toxic effects of sulfur mustard gas on Iranian victims. During a systematic search, a total of 193 (109 more
relevant to the main aim) articles on sulfur mustard gas were reviewed using known international and national
databases. No special evaluation was conducted on the quality of the articles and their publication in accredited
journals was considered sufficient. High rate of morbidities as the result of chemical attacks by sulfur mustard
among Iranian people occurred. Iranian researchers found a numerous late complications among the victims which
we be listed as wide range of respiratory, ocular, dermatological, psychological, hematological, immunological,
gastrointestinal and endocrine complications, all influenced the quality of life of exposed victims. The mortality rate
due to this agent was 3%. Although, mortality rate induced by sulfur mustard among Iranian people was low,
variety and chronicity of toxic effects and complications of this chemical agent were dramatic.
Keywords: Chemical injuries, Chemical victim, Chemical warfare agents (CWA), Sulfur mustard, Mustard gas, Toxic
effects of sulfur mustardBackground and history
Mustard gas or sulfur mustard is a chemical warfare
agent (King of the battle gases) [1] with cytotoxic, vesi-
cant and blistering effects on exposed skin [2]. This
agent can enter the body through various routes includ-
ing the skin, the respiratory system, conjunctiva and the
gastrointestinal system by contaminated foods [3]. It can
cause both acute and delayed manifestations and late
complications even 40 years after the exposure as
reported for victims of the first worldwar [4]. People can
be exposed to small or large amounts of mustard gas
through terroristic actions, wars, leakage from the fac-
tories, and even activities like fishing [5].
Sulfur mustard can be easily produced. It has a
delayed, extensive absorption, multi-organ effects and
quick penetration. It is stable in the environment, has a
low production cost, is easy to use and has the ability to* Correspondence: psalamati@tums.ac.ir
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reproduction in any medium, provided the ordebilitate soldiers [6,7]. After dissemination in an area,
mustard gas remains in that area for a long time and
makes that area non-habitable. Mustard gas victims tem-
porarily lose their vision a few hours after exposure
which is a critical strategy in warfare [7], and so far, it
has been used in >10 military conflicts [8].
Human losses related to destructive effects from this
agent in the World War l are as follow: the soldiers were
only equipped with protective breathing masks and lack of
skin protection resulted in the death of more than 90,000
soldiers and about 1.3 million injured people [8] and out of
which, 400,000 people required long term medical care [9].
According to the other reports mustard gas caused 14,000
injuries in the first 3 months of use in World War I and a
total of 120,000 injuries [10]. In the US army, out of the
total of 36,965 chemical warfare victims, 27,711 (75%) were
due to sulfur mustard gas, and according to a report from
the contamination control unit of the British army, of a
total of 160,970 chemically injured soldiers, 124,752
(77.5%) had been injured by sulfur mustard gas. The great-
est damage by chemical warfare agents in World War I
was done to the Russians resulting in 50,000 casualties andtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Historical evolution
Year Event Reference no.
1822 A type of Mustard gas was developed by
César-Mansuete Despretz, the Belgian scientist.
[8]
1860 Frederick Guthrie noted its blistering properties [1,8]
1886 Victor Meyer produced pure sulfur mustard. [1]
1917-1918 First use in World War I by the German
army - along 10 days about 1 million
sulfur mustard shells were poured on
Belgian soldiers. 1.3-2.5 million people in
Belgium and France and thousands of
British soldiers were injured.
[1,8,10]
1919 Production of mustard gas in American
factories reached 19 tons a day.
[7]
1925 Use of these agents was banned in
Geneva Gas Protocol.
[8]
1935- 1936 Italy breached the Geneva Protocol treaty
and used sulfur mustard gas against Ethiopia
when conquering the Ethiopian plane.
[8]
1943 A cargo ship carrying a large amount of
sulfur mustard exploded in the harbor
of Bari, Italy. The gas was disseminated
in the area injuring more than 600 people.
[1]
1937-1945 Japan used sulfur mustard gas against China. [8,10]
1945-1948 A large amount of sulfur mustard was
poured in the Baltic Sea. Exposure of
Scandinavian fishermen to this agent
resulted in development of skin blisters
[1]
1963-1967 Egypt used sulfur mustard bombs against
Yemeni pro-monarchy supporters.
[1,8]
1983-1988 Iraq extensively used SM and nerve agents
against Iran and injured more than 50,000
victims.
[8,9]
1988 Iraqi army killed 5,000 Iraqi civilians in
Halabcheh using SM. In this attack, nerve
agents like sarin were also used.
[1,8]
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in World War I, its delayed progressive and destructive
effects were recognized [7].
In the beginning of Iraq-Iran war in 1980, use of
chemical warfare agents was limited but in March 1985,
despite international conventions on prohibition of using
chemical warfare agents, Iraqis extensively used these
agents against Iran. They used nerve agents (Sarin &
Tabun) and mustard gas against Iranian soldiers [11,12].
According to data reported by Veterans and Martyrs
Affair Foundation (VMAF) which is responsible for tak-
ing care of the war victims in Iran, the Iranian people
were 387 times attacked with chemical bombs, rockets
and artillery shells during the 8-years war by Iraq
(1980–1988) [13]. More than 1,000 tons of sulfur mus-
tard was used in the battlefields [2] and about 100,000 of
people were injured due to this agent [8], as at the
present, after more than two decades, still about 30,000
of them are under treatment [14].
Sardasht is a city in north-west of Iran. Iraqis released
four 250 kg bombs containing mustard gas on this city
at 4 pm, July 27, 1987 injuring 4,500 civilians [15]. Use
of mustard gas against Iranian soldiers by the Iraqis was
reported to the international commissions by Iran in
1984 and in 1986 application of this agent by Iraqis was
documented by the United Nations observatory team led
by M. Dominguez [16]. They evaluated the battlefields,
clinically examined the victims and performed some
para-clinical tests and approved that Iraqis had used
chemical bombs containing mustard gas and to a lesser
extent organophosphorous nerve agents especially
Tabun [17].
Mustard gas was used by the Iraqis in south and west of
Iran many times and in 1988 the last chemical attack was
performed on Oshnaviyyeh city injuring 2,680 civilians
[13-18].
Definition and etiology
When mustard plants with the Latin name, Synapsis is
affected by the tyrosine glycoside Synacrine enzyme, a
substance is produced that naturally does not exist in
the seeds of this plant. This compound is isothiosyanate
which it is a vesicant agent [19]. Mustard compounds
are classified among the alkylating agents that substitute
hydrogen with an alkyl cation. A large group of these
compounds such as nitrogen mustards (chlorambucil) is
mainly used in medicine for treatment of cancers. The
other group namely sulfur mustard is considered a
chemical warfare agent used in many battlefields in the
20th century [3]. This agent is recognized with various
abbreviations H, HD, HT, LOST, SM (sulfur mustard),
MG (mustard Gas) and Y perit “H” and “HD” come
from the words “Hun Stuffe” and “Distilled”, HT is a
combination of 6% HD and 40% of a substance called Tand the LOST come from the name of the scientists
Lommel and Stein kopf, who developed a method for
the large-scale production of the agent for the German
army. French say to this agent, Y perit because it was
used in the Y pres at the first time [20].
Tables 1 and 2 indicate the history and properties of
sulfur mustard based on literature [1,3,6-10,18,21-26].
Pathology and mechanisms of actions
In summary, this alkylating substance leads to DNA
damage, cell membrane damage, decrease in glutathione,
activation of nuclear factor kappa-light-chain-enhancer
of activated B cells (NFkB), and caspase activation. DNA
damage lead to Poly (ADP-ribose) polymerase (PARP)
activation and nicotinic adenine nucleotide (NAD) de-
pletion and this process in turn will lead to necrosis.
Glutathione decreasing produce reactive oxygen and
these two phenomena may lead to necrosis and cell
death [27]. In addition to cell death, SM has many other
Table 2 Physical properties of sulfur mustard
Properties Description References
Formulation C4H8Cl2S [1,18]
2 side chains of dichloroethyl/sulfide or bis
(2-chloro-ethyl) sulfide
Color Colorless, lucent, or pale yellow (pure) to
yellow, brown, dark brown or black color
(impure).
[8,18]
Odor Sulfur mustard has a slight garlic, horseradish,
addled egg or fried vegetables or mustard
type odor.
[8,14,18]
Form Oily substance, liquid (in room temperature),
solid, powder (decontamination is much
more difficult), gas or vapor. It transforms





Solubility Lipophilic substance and highly fat soluble
(it can easily disseminate into skin, mucosa,
brain, kidneys, muscles and liver), negligible
solubility in water, may be hydrolyzed in
water and soluble in acetone. Water solubility
0.092 g/100 g at 22°C.
[3,8,22]
Stability In low temperatures, sulfur mustard remains
stable in clothing and soil for months. It
remains in the battlefields (for example
beside the moats in World War I) and can
be found in the amount of 1–25 mg/m3
in 6–12 inch depth of the soil. In moderate
temperatures with mild winds sulfur mustard
can remain stable for more than a week .
Different forms of SM can be stored in the
soil for up to 10 years.
[8,23]






14°C (its freezing point is decreased by
chlorobenzene)
[8]
Volatility 610 mg/m3 in 20°C [8]
Specific
Gravity
1.27(in liquid form than water and in gas
form is heavier than air)
[21,24]






SM evaporates at 15°C, in warm temperatures
becomes less stable and its vapor form
increases, and at night it sediments because
of decreased temperature.
[7]
Density SM is heavier than water when in the form of
liquid and heavier than air when in the form
of vapor or gas. Liquid density (1.274g/ml,
Vapor Density (5.4), Solid Density (Crystal)
1.37 g/ml at 20°C
[1,8]
Half life 5 min in 37°C [3]
Permeability SM penetrates the porous clothing and food
and plants, easily penetrates into the cell
membrane of most tissues, wood, leather (it
an permeate leather and regular clothing in a
few minutes and reach body tissues), rubber,
plastics (can easily pass through regular or
[7,23,25]
Table 2 Physical properties of sulfur mustard (Continued)
plastic breathing masks and rubber or plastic
clothing can protect the body for a few hours)




Eighty percent of the SM gas is evaporated
and the remaining 20% penetrates the body.
Of the 20%, 12% remains on the skin and 8%
is absorbed systemically. Absorption is done
through moist tissues like respiratory system,
axillary area, genital area/groins and eyes.
Tissues with higher metabolism are more
sensitive to this toxic gas.
[1,3,8,26]
Metabolites The main metabolite of SM in the urine is
thiodiglycol which can be detected by
chromatography with1ng /ml sensitivity.
[3]
Excretion Fifty percent of the absorbed SM in the body
is conjugated with aminoacid lecithin
producing di-cystylethyl sulfone which is
excreted through the kidneys.
[22]
Anti-toxin Unfortunately there is no specific antitoxin
for SM gas
[6]
Applications Except for chemical warfare, a nitrogen
analogue of SM is now being used in
chemotherapy for treatment of leukemia.
This therapeutic agent is called Mustargen
[1]
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inhibition (effects on hematologic system, immunologic
system, epithelial and germinal tissues), mutagenesis,
carcinogenesis, and colinomimethic effects [28].
On the basis of Kehe et al. study, in summary, mustard
gas in the molecular level induces the releasing of cyto-
kines, prostaglandines, matrix metalloproteinases (MMPs)
and serine proteases, and increases DNA damages, oxida-
tive stress, and impaired energy metabolism. Following to
these molecular changes, cellular infiltration, apoptosis and
necrosis occur that is continued by erythema and pain and
formation of vesicles, blisters, ulcer and impaired wound
healing [27].
Regarding above mechanisms, some authors suggeste
use of antioxidants, antiinflammatoriy, PARP inhibators
and N-acethyl-cystein (NAC) in treatment of SM toxicity.
Methods
During a systematic search, a total of 193 medical arti-
cles related to SM were reviewed using known inter-
national medical databases such as Scopus, Medline, ISI,
and Iranian medical databases such as Iranmedex, SID,
and Irandoc. One hundred and nine articles were more
relevant to the main aim. Eight articles were on general
aspects of SM effects, 36 articles were related to respira-
tory effects, 16 articles were on dermatologic effects, 15
articles were on ophthalmologic effects, 11 articles on
psychological effects, 10 articles on endocrinology & re-
productive health effects, 4 articles related to quality of
life and 9 articles were related to other items such as:
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tory. No special evaluation was conducted on the quality
of the reviewed manuscripts and the credit of journal
was considered sufficient. Our study had been handled
in accordance with the rules of the ethical review board
of Tehran University of medical sciences.
Results
Initial description of victims
Some Iranian soldiers described their first encounter with
SM as follows: immediately after exposure to the SM
bomb, we smelled a garlic odor and had a bitter taste in
our mouth. A few hours later, we became dizzy, with a
headache and we could not breathe. A short time after the
explosion, we developed small bleeding areas and inflamed
small lesions (macules and papules) on our skin. Then we
felt hoarseness in our voice and this condition has been
going on and off so far [28,29]. Also, some other victims
described the events at the exposure time as follows:
We were exposed to SM gas delivered through bomb
explosion from 5 to 30 meters distance. We smelled a
strong smell of garlic, addled egg or fried vegetables. A
bluish-grayish cloud and a white dust appeared in the
sky. We had no protection. In the first hours following
the attacks, we washed our faces and hands with waters
which we did not know the water may be contaminated
with SM [14]. Gradually, ocular, dermatologic and re-
spiratory symptoms developed. We are still suffering
from the related respiratory symptoms.
Mustard effects on body organs are divided into acute
and chronic phases. Most of the reviewed articles were
performed in chronic phase of exposure which they are
summarized in Table 3.
Percentage of organ involvement has been reported dif-
ferently in various Iranian studies. For example, Balali andTable 3 Distribution of pulmonary, ophthalmic and dermatolog




[30] Khateri 13 - 20 Mustard Veterans


















16 - 20 Mustard Veterans
[15] Ghanei 15 Mustard Civilian
population
[34] Emadi 14 - 20 Mustard +
Nerve agents
Veteranscolleagues (1992) in their study evaluated the delayed toxic
effects of mustard gas on 1,428 chemical victims 3–9 years
after exposure and reported the most prevalent complica-
tions to be respiratory complications (90%), dermatologic
complications (88%), ocular complications (78%), neural
complications (71%), GI complications (55%), genital com-
plications (52%) and hematopoietic system complications
(38%) [32].
In a study conducted on 100 Iranian chemical warfare
victims, 94% had dermatologic, 94% had ophthalmic, 75%
had pulmonary, 5% had GI and 10% had hematologic com-
plications as the result of chemical exposure [16].
In another study, delayed toxic effects of mustard gas
were evaluated in 236 Iranian chemical victims 2 to 28
months after exposure and complications were as fol-
lows: respiratory complications in 78%, CNS in 45% and
dermatologic complications in 24.5% of cases [35].
Table 3 shows distribution of pulmonary, ophthalmic
and dermatologic complications in several studies in
Iran [10,15,30-34].
According to report of Khateri and colleagues, the pul-
monary, ophthalmic and dermatologic complications
were the most common in 34,000 victims observed [30].
Complications
Mustard gas complications in Iranian victims were as
follows:
Respiratory system complications among Iranian Veterans
include
Obstruction of upper airways, chronic bronchitis, bron-
chiolitis, bronchiectasis [10,36], asthma [2,10], COPD
[37,38], emphysema, stenosis of large airways, pulmonary
fibrosis [10,39], thickening of the bronchial walls, air trap-







34000 93.3 42.5 24.5
50 86 100 98
600 37.7 45.8 31.5
1428 88 90 78
479 26 32.1 23.3
40 65 95 90
108 * 100 *
800 * * 100
Razavi et al. DARU Journal of Pharmaceutical Sciences 2012, 20:51 Page 5 of 8
http://www.darujps.com/content/20/1/51(BOOP) (a type of chronic pneumonia) [40], chronic laryn-
gitis and hoarseness of voice (acid like burning sensation)
[29], rhinopharyngitis, paranasal sinuses involvement, tra-
cheobronchitis [39], laryngeal carcinoma [10], lung cancer
in continuous exposure [18], tracheobronchomalacia [41],
airway collapse [18] and recurrent respiratory infections
and acute respiratory failure [1,2]. The main cause of death
in the soldiers who died immediately on the battlefield,
was probably pulmonary edema [29].
Ocular complications among Iranian victims were as follows
Eyelid edema, blepharospasm, chemosis, conjunctivitis,
limbal ischemia, limbal pigment loss, limbal loss, retina
ulcer, blurred vision, visual impairment, scarring and neo-
vascularization of the anterior chamber, uveitis, corneal
opacity, keratitis, corneal melting, calcium deposition, con-
junctivalization, perforation, and rarely blindness [4,7,10].
Dermatologic complications among Iranian injured
people were
Chronic dryness and pruritus, burning sensation,
increased sweating, hair loss, observation of erythema,
macular and popular rashes, vesicles, pustules, blisters,
ulcers, plaques, urticaria and angioedema, mustard scars,
cloid, hyper pigmentary, hypo and depigmentary lesions,
skin atrophy, lickenification, excoriation, scaling, neur-
osis, acne form lesions, melanocytic nevi, telangiectasia,
cherry angiomas, seborrhea dermatitis, tinea versiculer,
keratosis pillars, vitelligo, alopecia areata, liken planus,
actinic keratosis, and multiple basal cell carcinomas
[10,21,42-48].
Psychological complications among the Iranian victims
According to one study based on general health question-
naire, which were conducted on 206 victims from Sardasht
city (a city which were on direct attacks), 95.1% of them,
did not have a healthy psychological status [10]. Other in-
formation about the psychological disorders were: anxiety
15%, depression 46%, personality disorders 31%, psychosis
3% [32], post-traumatic stress disorder (PTSD) [10], “disor-
ders of consciousness (2%), attention (54%), emotion
(98%), behavior (80%), thought process (14%), and mem-
ory (80%) were reported, 3–5 years after exposure, by
Tabatabai and colleagues” [1] and decrease of self-steam
[49]. Madarshahian has reported some changes in current
life among exposed patients as follows: irregular sleep
(55%), nightmare (15%), using tobacco (60%), depression
(40%), bad mood and anger (40%), lack of interest in
social activities (44%), loss of confidence (55%), paranoia
(45%), nervousness (46%) [50].
Genital complications include
Sexual dysfunction, erectile dysfunction, impotence,
decreased libido, infertility, spermatological disorders,miscarriage in victims wives, premature ejaculation, con-
genital disorders in the newborns, late ejaculation or in-
ability to ejaculate [3,51].
Hematologic complications include
Leukopenia in the first days following exposure, decreased
T cells, anemia, thrombocytopenia [7], leukemia [21] and
hormonal changes [52].
Neurotoxicity include
Sever exposure to SM affects the CNS leading to convul-
sion in animal [53] as neurotoxicity (delayed neuropathy
syndrome) or chronic neuropathic pains has been reported
[16-30,32,35]. SM can cause [30]. Balali and colleagues per-
formed electromyography (EMG) and nerve conduction
velocity (NCV) on 40 Iranian soldiers and witnessed
delayed peripheral neuropathy in 77.5% of cases [1]. In a
study on 100 chemical victims, those who were severely
disabled had 4.09 times greater risk of developing neur-
opathy compared to those with moderate or mild disability.
NCV and EMG tests revealed that 5% of all under studied
victims had axonal neuropathy [16].
Other complications include
Decreased quality of life and sleep disorders as the result
of several physical (ophthalmologic injuries, pruritus,
COPD and . . .) and mental complications [9,54], con-
tamination of the wives of exposed soldiers [3,55]. Mus-
tard gas also can cause liver and kidney failure, skin
cancer, and bone marrow depression [56]. McNamara
and colleagues in their study on rats found that using
0.5 to 2 mg/kg mustard gas through the stomach tube in
days 6 and 15 of pregnancy caused no evidence of
teratogenicity [15,57].
The most prevalent GI complications in Iranian vic-
tims were nausea, vomiting, loss of appetite, stomach
pain and diarrhea. Mustard gas can cause stomach can-
cer, basal cell carcinoma, Bowen’s carcinoma and spino-
cellular carcinoma [1]. Mustard gas can eventually cause
death. However, the mortality rate is low (2 – 3%) [8,58].
Discussion
According to initial description of the victims, there is
a latent phase between the exposure and appearance
of symptoms. This time interval increases the morbid-
ity of exposed victims. Victims at first are not aware
of their exposure/contamination and as the result they
do not attempt to clean themselves which conse-
quently results in greater absorption of the toxic agent
into the tissues. This phase usually takes between 30
minutes to 8 hours [8].
To deal with this phase soldiers should train on how
to deal with chemical terrorism, especially with mustard
gas. For example, they should avoid washing their hand,
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because it may be contaminated with the poison.
Longitudinal studies showed that those exposed to
mustard gas suffer from long term complications caus-
ing significant morbidity [8]. There are 2 types of com-
plications: early and late. Early complications appear in
the first week following exposure but late complications
may manifest in the next 50 years following exposure
[10]. In chronic phase, patients may be suffering from
various diseases.
During World War I, scientists found that mustard gas
can cause bone marrow aplasia, dissolution of lymphoid
tissue and GI ulcers. Later many more complications were
reported due to mustard gas including respiratory, derma-
tologic, ocular, GI, hematopoietic, endocrine, neural, psy-
chological, ear-nose-throat (ENT), genital, reproductive
and immune system [21] involvement which can manifest
as early or delayed complications.
In Iranian studies, all the above mentioned effects have
been reported. Moreover, there are some studies about
sleep disorders [59], immunologic disorders [1,60], onco-
logic diseases [61], cardiologic diseases [62], exposed
military and civilian rights [63], abnormal lab examin-
ation results [64] and death among Iranian victims [56].
Mustard gas is a chemical warfare agent that is detri-
mental for the earth and has a significant toxic effect on
microorganisms in the soil. It also inhibits the enzymatic
activity of the soil [65]. On the other hand, SM can re-
main in the battlefields (for example beside the moats in
World War I) and can be found in the amount of 1–25
mg/m3 in 6–12 inch depth of the soil. In moderate tem-
peratures with mild winds SM can remain stable for
more than a week [8]. Different forms of SM can be
stored in the soil for up to 10 years [10]. Considering all
the above facts, since the war zones in our country now
are major tourist areas, and every year a large number of
people travel to these areas, healthy soil-building, should
strictly be placed on the agenda of the popular visits.
There are different reports about the prevalence of death
and its causes in Iranian veterans. Ghanei et al., in their
study have stated that, the rate of death among 1,005
people who died during their study period, were 72% by
diseases, 16.1% due to unintentional accidents, 2.3% due to
suicide, and 0.8% caused by intentional accidents. The
causes of deaths in 2.8% were uncertain and 12.1% of
deaths were related to chemical agents effects [66].
Tavallai et al., in their study conducted on 1239 Iranian
veterans also reported that 65.4% of deaths were due to
diseases, and 24.7% were due to accidents [67].
In summary, reported fatality rates in exposed soldiers
in World War 1 were less than 2% and among Iranian
victims were 3-4% and disabling potential of SM is much
greater than lethality of this agent [68]. According to
Tavallai report, the most common causes, had led todeath were cardiac diseases and this according to an
other report, in Iranian victims 75% of deaths were due
to respiratory complications [18], and many of Iranian
soldiers lost their lives in a chemical battle scene and
probably the cause of death was pulmonary edema
induced by chemical agents (29).
Conclusion
Although, mortality rate induced by sulfur mustard
among Iranian people was low, the variety and chron-
icity of adverse effects and complications of this chem-
ical agent were dramatic.
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